Investment Rating - The report initiates coverage with a "Buy" rating for the company, setting a target price of 7.00 HKD based on a 2026FY price-to-sales ratio of 7.7x [4]. Core Insights - The AI+ healthcare market is expected to grow rapidly, with specialized diagnostic products aligning well with hospital needs, driven by advancements in AI technology and supportive policies [15][21]. - The company, Yidu Technology, is a leading player in the AI+ healthcare sector, having developed its core AI algorithm, YiduCore, through extensive collaboration with top hospitals [3][30]. - The company has accumulated significant data processing experience, having handled over 11 billion patient interactions and 55 billion medical records, positioning it favorably in the industry [3][45]. Summary by Sections Investment Logic - The commercialization of AI in healthcare is accelerating, with 46 companies obtaining algorithm registrations related to health by the end of 2024 [2]. - AI-assisted specialized diagnosis and imaging recognition are particularly aligned with hospitals' revenue and reputation goals, leading to increased IT budget allocations [2]. Financial Performance and Forecast - The company is projected to achieve revenues of 777 million, 891 million, and 1.069 billion CNY for FY 2025, FY 2026, and FY 2027, respectively, with corresponding year-on-year growth rates of -3.78%, 14.69%, and 20.04% [4][8]. - The net profit forecast for the same period is -106 million, -50 million, and 6 million CNY, indicating a trend towards profitability by FY 2027 [4][8]. Business Structure and Adjustments - The company has a flexible business structure, allowing it to adjust its product offerings in response to market demands, which is expected to lead to continuous improvement in profitability [53]. - The company serves over 2,800 hospitals and has established partnerships with 105 top hospitals, maintaining a leading market share in clinical research [9][33]. AI Platform and Model Development - The company launched an AI platform that integrates various medical applications, which has been deployed in over 20 medical institutions, supporting revenue growth [3][48]. - YiduCore's capabilities have been validated through multiple industry assessments, ranking first in various evaluations, which enhances the company's competitive edge [45][52]. Market Trends and Opportunities - The AI+ healthcare market is witnessing a surge in demand for specialized diagnostic solutions, driven by technological advancements and favorable regulatory environments [15][21]. - The company is well-positioned to capitalize on this growth due to its extensive data processing capabilities and established relationships with leading healthcare institutions [30][41].
医渡科技（02158）：合作顶级医院+深耕数据治理，AI驱动增长提速